Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2592dbfe4a42dee15798c82271ff1b0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-28 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 |
filingDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba95d5df9c5d2decdadb834ad327239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3abd885a80571921e623f6ef2b7bec26 |
publicationDate |
2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120029267-A |
titleOfInvention |
Use of DNA-PI inhibitors to induce differentiation of mesenchymal stem cells into vascular endothelial cells |
abstract |
The present invention provides a pharmaceutical composition for treating vascular diseases, including the use of a DNA-PK inhibitor for inducing differentiation of mesenchymal stem cells into vascular endothelial cells and vascular endothelial cells differentiated from mesenchymal stem cells by a DNA-PK inhibitor. To provide. Since mesenchymal stem cells treated with DNA-PK inhibitors are specifically induced to differentiate into vascular endothelial cells, it is possible to effectively treat vascular diseases such as vascular endothelial cell damage caused by balloon dilation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101490695-B1 |
priorityDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |